vs

Side-by-side financial comparison of BEAZER HOMES USA INC (BZH) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $409.8M, roughly 1.8× BEAZER HOMES USA INC). On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -47.0%). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -28.7%).

Beazer Homes USA, Inc. is a home construction company based in Atlanta, Georgia. In 2016, the company was the 11th largest home builder in the United States based on the number of homes closed. The company operates in 13 states.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

BZH vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.8× larger
DOC
$719.4M
$409.8M
BZH
Growing faster (revenue YoY)
DOC
DOC
+50.1% gap
DOC
3.1%
-47.0%
BZH
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-28.7%
BZH

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BZH
BZH
DOC
DOC
Revenue
$409.8M
$719.4M
Net Profit
$114.0M
Gross Margin
11.9%
Operating Margin
17.4%
Net Margin
73.2%
Revenue YoY
-47.0%
3.1%
Net Profit YoY
2406.4%
EPS (diluted)
$-0.03
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BZH
BZH
DOC
DOC
Q2 26
$409.8M
Q1 26
$363.5M
Q4 25
$363.5M
$719.4M
Q3 25
$791.9M
$705.9M
Q2 25
$545.4M
$694.3M
Q1 25
$565.3M
$702.9M
Q4 24
$469.0M
$698.0M
Q3 24
$806.2M
$700.4M
Net Profit
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
$-32.6M
$114.0M
Q3 25
$30.0M
$-117.1M
Q2 25
$-324.0K
$31.7M
Q1 25
$12.8M
$42.8M
Q4 24
$3.1M
$4.5M
Q3 24
$52.1M
$85.9M
Gross Margin
BZH
BZH
DOC
DOC
Q2 26
11.9%
Q1 26
10.2%
Q4 25
10.2%
Q3 25
13.5%
58.6%
Q2 25
13.3%
60.2%
Q1 25
15.2%
61.1%
Q4 24
15.4%
60.3%
Q3 24
17.5%
60.0%
Operating Margin
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
-8.8%
17.4%
Q3 25
3.1%
9.2%
Q2 25
-0.7%
5.7%
Q1 25
2.4%
7.7%
Q4 24
0.5%
-2.2%
Q3 24
7.2%
14.1%
Net Margin
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
-9.0%
73.2%
Q3 25
3.8%
-16.6%
Q2 25
-0.1%
4.6%
Q1 25
2.3%
6.1%
Q4 24
0.7%
0.7%
Q3 24
6.5%
12.3%
EPS (diluted)
BZH
BZH
DOC
DOC
Q2 26
$-0.03
Q1 26
$-1.13
Q4 25
$-1.13
$0.16
Q3 25
$1.01
$-0.17
Q2 25
$-0.01
$0.05
Q1 25
$0.42
$0.06
Q4 24
$0.10
$0.02
Q3 24
$1.69
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BZH
BZH
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$116.4M
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$1.2B
$7.5B
Total Assets
$2.8B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BZH
BZH
DOC
DOC
Q2 26
$116.4M
Q1 26
$120.8M
Q4 25
$120.8M
$467.5M
Q3 25
$214.7M
$91.0M
Q2 25
$82.9M
$89.4M
Q1 25
$85.1M
$70.6M
Q4 24
$80.4M
$119.8M
Q3 24
$203.9M
$180.4M
Total Debt
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Stockholders' Equity
BZH
BZH
DOC
DOC
Q2 26
$1.2B
Q1 26
$1.2B
Q4 25
$1.2B
$7.5B
Q3 25
$1.2B
$7.6B
Q2 25
$1.2B
$7.9B
Q1 25
$1.2B
$8.2B
Q4 24
$1.2B
$8.4B
Q3 24
$1.2B
$8.6B
Total Assets
BZH
BZH
DOC
DOC
Q2 26
$2.8B
Q1 26
$2.6B
Q4 25
$2.6B
$20.3B
Q3 25
$2.6B
$19.6B
Q2 25
$2.7B
$19.8B
Q1 25
$2.7B
$19.8B
Q4 24
$2.6B
$19.9B
Q3 24
$2.6B
$20.0B
Debt / Equity
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BZH
BZH
DOC
DOC
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
$-165.3M
$1.3B
Q3 25
$250.2M
$315.0M
Q2 25
$-62.3M
$363.5M
Q1 25
$3.4M
$279.4M
Q4 24
$-159.4M
$1.1B
Q3 24
$185.4M
$318.2M
Free Cash Flow
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
$-170.9M
$357.0M
Q3 25
$242.7M
Q2 25
$-70.2M
Q1 25
$-4.4M
Q4 24
$-164.6M
$333.7M
Q3 24
$179.8M
FCF Margin
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
-47.0%
49.6%
Q3 25
30.6%
Q2 25
-12.9%
Q1 25
-0.8%
Q4 24
-35.1%
47.8%
Q3 24
22.3%
Capex Intensity
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
1.5%
124.4%
Q3 25
0.9%
Q2 25
1.5%
Q1 25
1.4%
Q4 24
1.1%
105.6%
Q3 24
0.7%
Cash Conversion
BZH
BZH
DOC
DOC
Q2 26
Q1 26
Q4 25
10.99×
Q3 25
8.34×
Q2 25
11.48×
Q1 25
0.27×
6.52×
Q4 24
-50.92×
235.43×
Q3 24
3.56×
3.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BZH
BZH

West region$231.3M56%
East region$90.8M22%
Southeast region$75.7M18%
Land sales and other$12.1M3%

DOC
DOC

Segment breakdown not available.

Related Comparisons